Drug Profile
Butabindide
Alternative Names: UCL 1397Latest Information Update: 26 Feb 2001
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Class Indoles; Small molecules
- Mechanism of Action Peptide hydrolase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Obesity
Most Recent Events
- 26 Feb 2001 No-Development-Reported for Obesity in France (Unknown route)
- 20 Feb 1998 Preclinical development for Obesity in France (Unknown route)